The Coinbase Premium Index has remained negative for over 900 consecutive hours, marking its longest streak in two years. This index measures the price difference of Bitcoin between Coinbase Advanced, favored by institutional investors, and Binance, which serves a broader user base. The prolonged negative reading indicates that professional investors have been consistently selling Bitcoin on Coinbase, reflecting ongoing caution amid macroeconomic uncertainties like inflation, oil prices, and unclear Federal Reserve policies. This sustained trend suggests institutions are prioritizing risk reduction, and a return to positive territory on the index could signal improving institutional sentiment toward Bitcoin.
Benchmark has reiterated its Buy rating for Coinbase, highlighting the company's expansion of its "Everything Exchange" platform, which aims to integrate various trading activities into one system. Coinbase is also pursuing international growth, nota...
GE Vernova reported Q2 2026 earnings with an EPS of $2.47, missing the consensus estimate of $3.17, while revenue rose 22% year-over-year to $11.10 billion, beating expectations. Despite strong top-line growth and an upgraded full-year outlook, share...
Packaging Corporation of America is set to release its Q2 2026 earnings on July 22, with analysts expecting revenue of $2.40 billion, a 10.7% increase from last year, driven by higher packaging volume and pricing. However, earnings per share are fore...
The global automotive pumps market is projected to grow from $31.11 billion in 2026 to $34.15 billion by 2035, at a CAGR of 1.0%. Growth is driven by increased pump content in passenger cars, especially for engine and HVAC systems, as OEMs adopt adva...
Celldex Therapeutics lowered its price target from $67 to $61 after stopping its Phase 2 trial for barzolvolimab, a drug for prurigo nodularis, because it failed to meet primary efficacy goals. Despite this setback, the drug showed a strong safety pr...
